Prostaglandin E1 in infants with congenital heart disease: Indian experience

Indian Pediatrics

Volumn 35, Issue 11, 1998, Pages 1063-1069

  Saxena, Anita ^a   Sharma, M ^a   Kothari, S S ^a   Juneja, R ^a   Reddy, S C B ^a   Sharma, R ^a   Bhan, A ^a   Venugopal, P ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Congenital heart disease; Patent ductus arteriosus; Prostaglandin E1

Indexed keywords

PROSTAGLANDIN E1; VASODILATOR AGENT;

AGE; ARTICLE; CLINICAL TRIAL; CONGENITAL HEART MALFORMATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ECHOGRAPHY; FEMALE; FOLLOW UP; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEWBORN; PATENT DUCTUS ARTERIOSUS; PATHOPHYSIOLOGY; TREATMENT OUTCOME; AORTA ARCH INTERRUPTION; AORTA COARCTATION; APNEA; CONGENITAL HEART DISEASE; DRUG EFFICACY; DRUG INDICATION; GREAT VESSELS TRANSPOSITION; HEART LEFT VENTRICLE VOLUME; HYPERPYREXIA; HYPOPLASTIC LEFT HEART SYNDROME; INDIA; LUNG ATRESIA; LUNG BLOOD FLOW; MAJOR CLINICAL STUDY; NECROTIZING ENTEROCOLITIS; NERVOUSNESS; PULMONARY VALVE STENOSIS; RASH; TRICUSPID VALVE ATRESIA;

AGE FACTORS; ALPROSTADIL; DUCTUS ARTERIOSUS, PATENT; FEMALE; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HEMODYNAMIC PROCESSES; HUMANS; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; MALE; STROKE VOLUME; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0032198098     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Coceani F, Olley PM. The response of the ductus arteriosus to prostaglandins. Can J Physiol Pharmcol 1973; 51: 220-225.
2. Elliot RB, Starling MB, Neutze JM. Medical manipulation of the ductus arteriosus. Lancet 1975; 1: 140-142.
3. Olley PM, Coceani F, Bodach E. E type prostaglandins. A new emergency therapy for certain cyanotic congenital heart malformations. Circulation 1976; 53: 728-731.
4. Neutz JM, Starling MB, Elliot RB, Barrett-Boyes BG. Palliation of cyanotic congenital heart disease in infants with E type prostaglandins. Circulation 1977; 55: 238-241.
5. 1 in aortic arch abnormalities. Circulation 1979; 59: 169-173.
6. 1 in infants with ductus arteriosus dependent congenital heart disease. Circulation 1981; 64: 899-904.
7. 1 in infants with d-transposition of the great arteries and an intact ventricular septum. Am J Cardiol 1979; 44: 76-81.
8. 1 infusion in the management of transposition of great arteries. Am J Cardiol 1979; 44: 691-696.
9. 1 in neonates with critical congenital cardiac defects. J Pediatr 1978; 93: 481-485.
10. 1 infusion in newborns with hypoplastic left ventricle and aortic atresia. Pediatr Cardiol 1982; 2: 95-98.
11. Rudolph AM. The ductus arteriosus and persistent patency of ductus arteriosus. In: Congenital Disease of the Heart. Chicago, Year Book Medical Publishers, 1974; p 172.
12. Freedom RM, Olley PM, Coceani F, Rowe RD. The prostaglandin challenge. Test to unmask obstructed total anomalous pulmonary venous connections in asplenic syndrome. Br Heart J 1978; 40: 91-94.
13. Yasui H, Kado H, Yonenaga K, Hisahara M, Ando H, Iwao H, et al. Arterial switch operation for transposition of the great arteries, with special reference to left ventricular function. J Thorac Cardiovasc Surg 1989; 98: 601-610.
14. 1 in infants with critical congenital heart disease. Circulation 1981; 64: 893-898.
15. 1 suspected ductus dependent cardiac malformation. Arch Dis Child 1984; 59: 1020-1026.
16. Singh GK, Fong LV, Salmon AP, Keeton BR. Study of low dosage prostaglandin-usages and complications. Europ Heart J 1994; 15: 377-381.
17. Silove E. Administration of E type prostaglandins in congenital heart disease. Pediatr Cardiol 1982; 2: 303-305.